𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit β5t

✍ Scribed by Adiratna Mat Ripen; Takeshi Nitta; Shigeo Murata; Keiji Tanaka; Yousuke Takahama


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
704 KB
Volume
41
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Co-expression of CD8α in CD4+ T cell rec
✍ Jörg Reimann; Angelika Rudolphi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 959 KB

## Abstract We investigated the surface phenotype of CD3^+^CD4^+^ T cell receptor (TCR) αβ^+^ T cells repopulating the intestinal lymphoid tissues of C.B‐17 __scidlscid__ (__severe__‐combined immunodeficient; scid) (H‐2^d^, L^d+^) mice. CD4^+^ CD8^−^ T cells were cell sorter‐purified from various s

p38 MAPK is a critical regulator of the
✍ Fabrizio Mainiero; Michaela Colombara; Valeria Antonini; Raffaele Strippoli; Mar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

## Abstract Cytokines and adhesion receptors are key mediators in the dialog occurring between thymic epithelial cells (TEC) and thymocytes and regulating T cell maturation and epithelial embryonic differentiation. Among cytokines, IL‐6 can be critical in the thymus, fostering proliferation, differ

Induction or suppression of expression o
✍ Yanbo Sun; Hong Lin; Yunfeng Zhu; Cuiling Ma; Jianping Ye; Jia Luo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

## Abstract The ErbB family of receptor kinases is composed of four members: epidermal growth factor receptor (EGFR/ErbB1), ErbB2/neu, ErbB3, and ErbB4. Amplification of the ErbB2/neu is found in about 30% of breast cancer patients and is associated with a poor prognosis. Heregulin (HRG) activates

Response of normal and oncogene-transfor
✍ Fulvio Basolo; Lisa Fiore; Fortunato Ciardiello; Simonetta Calvo; Gabriella Font 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 825 KB

The relationship between the expression of selected oncogenes having different modes of action and the loss of the capacity t o respond in vitro to transforming growth factor+ I (TGF-P I) was analyzed in human mammary epithelial cells (MEC). Primary MEC cultures from healthy donors and the spontaneo